# Parkman Healthcare Partners LLC 13F Q2 2026: $977 million

Parkman Healthcare Partners LLC reported $977 million in 13F securities across 77 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was MBX Biosciences Inc at $44.2 million, 4.5% of the reported value. Since Q1 2026 it opened 18 new positions and exited 31.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $976,827,960
- Positions: 77
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1777015
- Form 13F file number: 028-19992
- CRD number: 300701
- Business address: 700 Canal Street 2nd Floor, Stamford, CT 06902
- SEC filing: [0001420506-26-001734](https://www.sec.gov/Archives/edgar/data/1777015/000142050626001734/0001420506-26-001734-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/parkman-healthcare-partners-llc-300701)

## Top 25 holdings by value

The largest of 77 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 800,173 | $44.2 million | +136 |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 35,000 | $42 million | +384 |
| [CVS Health Corp](https://specstream.ai/data/institutional-holders/cvs-health-corp-126650100) | COM | 391,791 | $40.5 million | +4,485 |
| [Dexcom Inc](https://specstream.ai/data/institutional-holders/dexcom-inc-252131107) | COM | 534,767 | $36 million | -155,055 |
| [PTC Therapeutics Inc](https://specstream.ai/data/institutional-holders/ptc-therapeutics-inc-69366j200) | COM | 435,691 | $35.5 million | +4,327 |
| [Arcus Biosciences Inc](https://specstream.ai/data/institutional-holders/arcus-biosciences-inc-03969f109) | COM | 919,266 | $28.3 million | -288,008 |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 485,661 | $26.1 million | +253,568 |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 1,377,576 | $25.3 million | +819,640 |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 669,046 | $24.8 million | +265,521 |
| [Inhibrx Biosciences Inc](https://specstream.ai/data/institutional-holders/inhibrx-biosciences-inc-45720n103) | COM | 256,950 | $24.3 million | New |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 397,379 | $24 million | -99,656 |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 577,036 | $23.4 million | +254,208 |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 55,921 | $23.2 million | New |
| [Stryker Corporation](https://specstream.ai/data/institutional-holders/stryker-corporation-863667101) | COM | 67,973 | $21.4 million | -86,798 |
| [Iqvia Hldgs Inc](https://specstream.ai/data/institutional-holders/iqvia-hldgs-inc-46266c105) | COM | 105,811 | $20.4 million | +19,109 |
| [Zimmer Biomet Holdings Inc](https://specstream.ai/data/institutional-holders/zimmer-biomet-holdings-inc-98956p102) | COM | 232,557 | $20 million | -37,000 |
| [Insulet Corp](https://specstream.ai/data/institutional-holders/insulet-corp-45784p101) | COM | 131,378 | $20 million | -25,183 |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 721,181 | $19.8 million | +309,954 |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 877,256 | $19.2 million | -24,255 |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 1,288,163 | $18.4 million | -66,637 |
| [Tenet Healthcare Corp](https://specstream.ai/data/institutional-holders/tenet-healthcare-corp-88033g407) | COM NEW | 97,280 | $18.2 million | +47,157 |
| [Livanova PLC](https://specstream.ai/data/institutional-holders/livanova-plc-g5509l101) | SHS | 210,529 | $17.3 million | -193,436 |
| [Ani Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ani-pharmaceuticals-inc-00182c103) | COM | 202,907 | $16.8 million | -77,668 |
| [Biocryst Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/biocryst-pharmaceuticals-inc-09058v103) | COM | 1,624,279 | $16.2 million | -83,820 |
| [Alnylam Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/alnylam-pharmaceuticals-inc-02043q107) | COM | 50,672 | $15.3 million | +23,756 |

## New positions in Q2 2026

18 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Inhibrx Biosciences Inc](https://specstream.ai/data/institutional-holders/inhibrx-biosciences-inc-45720n103) | COM | 256,950 | $24.3 million |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 55,921 | $23.2 million |
| [Indivior Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/indivior-pharmaceuticals-inc-45579u109) | COM | 364,269 | $14.9 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 766,290 | $14.2 million |
| [Alto Neuroscience Inc](https://specstream.ai/data/institutional-holders/alto-neuroscience-inc-02157q109) | COM SHS | 429,035 | $11.3 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 113,188 | $10.8 million |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 150,000 | $9.4 million |
| [Cryoport Inc](https://specstream.ai/data/institutional-holders/cryoport-inc-229050307) | COM PAR $0.001 | 508,324 | $8 million |
| [Climb Bio Inc](https://specstream.ai/data/institutional-holders/climb-bio-inc-28658r106) | COM | 563,484 | $7.3 million |
| [Resmed Inc](https://specstream.ai/data/institutional-holders/resmed-inc-761152107) | COM | 32,983 | $6.4 million |
| [Aveanna Healthcare Hldgs Inc](https://specstream.ai/data/institutional-holders/aveanna-healthcare-hldgs-inc-05356f105) | COM | 714,451 | $6.1 million |
| [Shoulder Innovations Inc](https://specstream.ai/data/institutional-holders/shoulder-innovations-inc-82537j108) | COMMON STOCK | 226,212 | $4.6 million |
| [Eikon Therapeutics Inc](https://specstream.ai/data/institutional-holders/eikon-therapeutics-inc-282564103) | COM | 256,053 | $3.3 million |
| [Viatris Inc](https://specstream.ai/data/institutional-holders/viatris-inc-92556v106) | COM | 200,000 | $3.2 million |
| Grail Inc | PUT (put) | 46,000 | $3.1 million |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 10,000 | $2.4 million |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 45,000 | $1.7 million |
| [Ars Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ars-pharmaceuticals-inc-82835w108) | COM | 102,700 | $822,627 |

## Positions exited in Q2 2026

31 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Kalvista Pharmaceuticals Inc | COM | 1,835,506 | $36.9 million |
| [Qiagen NV](https://specstream.ai/data/institutional-holders/qiagen-nv-n72482156) | ORD SHARES | 500,000 | $20 million |
| [Abbvie Inc](https://specstream.ai/data/institutional-holders/abbvie-inc-00287y109) | COM | 75,000 | $16.3 million |
| [Illumina Inc](https://specstream.ai/data/institutional-holders/illumina-inc-452327109) | COM | 110,370 | $13.6 million |
| [Edwards Lifesciences Corp](https://specstream.ai/data/institutional-holders/edwards-lifesciences-corp-28176e108) | COM | 167,155 | $13.4 million |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 99,069 | $13.1 million |
| [Kiniksa Pharmaceuticals Intl](https://specstream.ai/data/institutional-holders/kiniksa-pharmaceuticals-intl-g52694109) | ORD SHS CL A | 259,184 | $12.5 million |
| [McKesson Corp](https://specstream.ai/data/institutional-holders/mckesson-corp-58155q103) | COM | 12,676 | $11 million |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 88,078 | $9 million |
| [Axogen Inc](https://specstream.ai/data/institutional-holders/axogen-inc-05463x106) | COM | 268,160 | $8.9 million |
| [Idexx Labs Inc](https://specstream.ai/data/institutional-holders/idexx-labs-inc-45168d104) | COM | 15,000 | $8.4 million |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 77,686 | $6.5 million |
| [Cooper Cos Inc](https://specstream.ai/data/institutional-holders/cooper-cos-inc-216648501) | COM | 89,883 | $6.4 million |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 266,127 | $5.6 million |
| Moderna Inc | PUT (put) | 100,000 | $5.1 million |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 235,000 | $4.9 million |
| [Supernus Pharmaceuticals](https://specstream.ai/data/institutional-holders/supernus-pharmaceuticals-868459108) | COM | 85,062 | $4.4 million |
| [Caris Life Sciences Inc](https://specstream.ai/data/institutional-holders/caris-life-sciences-inc-142152107) | COM | 229,912 | $4.1 million |
| [CVRX Inc](https://specstream.ai/data/institutional-holders/cvrx-inc-126638105) | COM | 429,507 | $4.1 million |
| [Genedx Holdings Corp](https://specstream.ai/data/institutional-holders/genedx-holdings-corp-81663l200) | COM CL A | 50,778 | $3.3 million |
| [Veracyte Inc](https://specstream.ai/data/institutional-holders/veracyte-inc-92337f107) | COM | 101,237 | $3.3 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 554,411 | $3.1 million |
| [Solid Biosciences Inc](https://specstream.ai/data/institutional-holders/solid-biosciences-inc-83422e204) | COM NEW | 308,844 | $2.2 million |
| [Butterfly Network Inc](https://specstream.ai/data/institutional-holders/butterfly-network-inc-124155102) | COM CL A | 544,477 | $2.2 million |
| [Quidelortho Corp](https://specstream.ai/data/institutional-holders/quidelortho-corp-219798105) | COM | 101,764 | $1.7 million |

## Also on SpecStream

- [Parkman Healthcare Partners LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1777015/000142050626001734/0001420506-26-001734-index.htm)
- [Parkman Healthcare Partners LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/parkman-healthcare-partners-llc-300701)
- [Largest 13F filers in Connecticut](https://specstream.ai/data/institutional-holdings/state/connecticut)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Stamford, Connecticut

- [Investment management firms in Stamford, Connecticut](https://specstream.ai/data/businesses/investment-management-firms/stamford-connecticut-united-states)
- [Mortgage lenders in Stamford, Connecticut](https://specstream.ai/data/businesses/mortgage-lenders/stamford-connecticut-united-states)
- [Banks and credit unions in Stamford, Connecticut](https://specstream.ai/data/businesses/banks-and-credit-unions/stamford-connecticut-united-states)
- [Employment agencies in Stamford, Connecticut](https://specstream.ai/data/businesses/employment-agencies/stamford-connecticut-united-states)
- [IT service companies in Stamford, Connecticut](https://specstream.ai/data/businesses/it-service-companies/stamford-connecticut-united-states)
- [Physical therapy clinics in Stamford, Connecticut](https://specstream.ai/data/businesses/physical-therapy-clinics/stamford-connecticut-united-states)
